Related references
Note: Only part of the references are listed.New players on the center stage: Sphingosine 1-phosphate and its receptors as drug targets
Andrea Huwiler et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Effects of phosphorylation of immunomodulatory agent FTY720 (fingolimod) on antiproliferative activity against breast and colon cancer cells
Yasuo Nagaoka et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)
Novel analogs of D-e-MAPP and B13.: Part 2:: Signature effects on bioactive sphingolipids
Alicja Bielawska et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Sphingosine Kinase 1: A New Modulator of Hypoxia Inducible Factor 1α during Hypoxia in Human Cancer Cells
Isabelle Ader et al.
CANCER RESEARCH (2008)
Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function
Suleiman Massarweh et al.
CANCER RESEARCH (2008)
Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development
Melissa A. Tran et al.
CLINICAL CANCER RESEARCH (2008)
The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer: Results of a phase I study with pharmacokinetics
Ahmad Awada et al.
EUROPEAN JOURNAL OF CANCER (2008)
Principles of bioactive lipid signalling: lessons from sphingolipids
Yusuf A. Hannun et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
"Inside-Out" Signaling of Sphingosine-1-Phosphate: Therapeutic Targets
K. Takabe et al.
PHARMACOLOGICAL REVIEWS (2008)
Tamoxifen-stimulated growth of breast cancer due to p21 loss
Abde M. Abukhdeir et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer
Eugen Ruckhaeberle et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells
Valerie Gouaze-Andersson et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin
Heidi M. Sankala et al.
CANCER RESEARCH (2007)
Tumor cell apoptosis polarizes macrophages -: Role of sphingosine-1-phosphate
Andreas Weigert et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Autocrine and paracrine roles of sphingosine-1-phosphate
Sergio E. Alvarez et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2007)
Bioinformatics-based discovery and characterization of an AKT-selective inhibitor 9-chloro-2-methylellipticinium acetate (CMEP) in breast cancer cells
Manchao Zhang et al.
CANCER LETTERS (2007)
Identification of Key Processes Underlying Cancer Phenotypes Using Biologic Pathway Analysis
Sol Efroni et al.
PLOS ONE (2007)
Enhanced NFκB and AP-I transcriptional activity associated with antiestrogen resistant breast cancer
Yamei Zhou et al.
BMC CANCER (2007)
Anticlusterin treatment of breast cancer cells increases the sensitivities of chemotherapy and tamoxifen and counteracts the inhibitory action of dexamethasone on chemotherapy-induced cytotoxicity
Maximino Redondo et al.
BREAST CANCER RESEARCH (2007)
Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases
Nitai C. Hait et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2006)
Sphingosine kinase-1 is cleaved by cathepsin B in vitro: Identification of the initial cleavage sites for the protease
Tarek A. Taha et al.
FEBS LETTERS (2006)
Targeting sphingosine-I-phosphate for cancer therapy
R. A. Sabbadini
BRITISH JOURNAL OF CANCER (2006)
Can NF-κB be a target for novel and efficient anti-cancer agents?
Sabine Olivier et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line
Aline A. Fiebig et al.
BMC CANCER (2006)
Activation of nuclear factor-κ B is linked to resistance to neloadjuvant chemotherapy in breast cancer patients
C. Montagut et al.
ENDOCRINE-RELATED CANCER (2006)
Functional estrogen receptors in the mitochondria of breast cancer cells
A Pedram et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1
O Sukocheva et al.
JOURNAL OF CELL BIOLOGY (2006)
Regulation of autophagy by sphingosine kinase 1 and its role in cell survival during nutrient starvation
G Lavieu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Laser microdissection and microarray analysis of breast tumors reveal ER-α related genes and pathways
F Yang et al.
ONCOGENE (2006)
Lethal endotoxic shock using α-galactosylceramide sensitization as a new experimental model of septic shock
H Ito et al.
LABORATORY INVESTIGATION (2006)
Dexamethasone protection from TNF-alpha-induced cell death in MCF-7 cells requires NF-kappaB and is independent from AKT
C Machuca et al.
BMC CELL BIOLOGY (2006)
Interleukin-1β induction of NFκB is partially regulated by H2O2-mediated activation of NFκb-inducing kinase
Q Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-jun NH2-Terminal kinase and Akt
A Sunters et al.
CANCER RESEARCH (2006)
Fumonisin B1 induces necrotic cell death in BV-2 cells and murine cultured astrocytes and is antiproliferative in BV-2 cells while N2A cells and primary cortical neurons are resistant
MF Osuchowski et al.
NEUROTOXICOLOGY (2005)
Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells
S Sarkar et al.
FEBS LETTERS (2005)
Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumor invasion
Lingegowda S. Mangala et al.
MOLECULAR CANCER (2005)
Inhibition of mTOR and estrogen receptor signaling in vitro induces cell death in models of breast cancer
A Boulay et al.
CLINICAL CANCER RESEARCH (2005)
Acid sphingomyelinase is indispensable for UV light-induced bax conformational change at the mitochondrial membrane
H Kashkar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma
TC Stover et al.
CLINICAL CANCER RESEARCH (2005)
Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs
V Gouazé et al.
CANCER RESEARCH (2005)
Positively charged ceramide is a potent inducer of mitochondrial permeabilization
SA Novgorodov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Formation of an IKKα-dependent transcription complex is required for estrogen receptor-mediated gene activation
KJ Park et al.
MOLECULAR CELL (2005)
A mitochondrial pool of sphingomyelin is involved in TNFα-induced Bax translocation to mitochondria
H Birbes et al.
BIOCHEMICAL JOURNAL (2005)
Selective inhibition of juxtanuclear translocation of protein kinase C βII by a negative feedback mechanism involving ceramide formed from the salvage pathway
KP Becker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
PI3K/Akt/mTOR pathway as a target for cancer therapy
D Morgensztern et al.
ANTI-CANCER DRUGS (2005)
Differential regulation of signal transduction pathways in wild type and mutated p53 breast cancer epithelial cells by copper and zinc
EA Ostrakhovitch et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2004)
Physiological and pathological actions of sphingosine 1-phosphate
T Hla
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2004)
Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer
EA Curry et al.
INVESTIGATIONAL NEW DRUGS (2004)
Mechanisms of tamoxifen resistance: Increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer
J Shou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Novel ceramide analogs as potential chemotherapeutic agents in breast cancer
AP Struckhoff et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Sphingosine kinase transmits estrogen signaling in human breast cancer cells
OA Sukocheva et al.
MOLECULAR ENDOCRINOLOGY (2003)
Apoptosis, chemoresistance, and breast cancer: Insights from the MCF-7 cell model system
R Simstein et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2003)
Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells
VE Nava et al.
EXPERIMENTAL CELL RESEARCH (2002)
Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts
F Wang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity
V Brinkmann et al.
CURRENT OPINION IN IMMUNOLOGY (2002)
The ceramide-centric universe of lipid-mediated cell regulation: Stress encounters of the lipid kind.
YA Hannun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The protein kinase B/Akt signalling pathway in human malignancy
KM Nicholson et al.
CELLULAR SIGNALLING (2002)
Cardiovascular changes associated with intravenous administration of fumonisin B1 in horses
GW Smith et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2002)
NF-κB-mediated chemoresistance in breast cancer cells
CB Weldon et al.
SURGERY (2001)
Taxol-induced ceramide generation and apoptosis in human breast cancer cells
AG Charles et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2001)
Targeting ceramide metabolism - a strategy for overcoming drug resistance
A Sanchenkov et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Combined cytotoxic action of paclitaxel and ceramide against the human Tu138 head and neck squamous carcinoma cell line
S Mehta et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2000)
Share Paper
